ReviewFrontiers in immunology2022

Immunotherapy for EGFR-mutant advanced non-small-cell lung cancer: Current status, possible mechanisms and application prospects.

Chunyan Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.